Interferon-gamma release assay for the diagnosis of latent TB infection - Analysis of discordant results, when compared to the tuberculin skin test

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Nienhaus, Albert ^a   Schablon, Anja ^a   Diel, Roland ^b  

^a Department of Occupational Health Research ^*  (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION; BLOOD; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; INFANT; METABOLISM; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; INTERFERON TYPE II; MALE; MIDDLE AGED; TUBERCULIN TEST; TUBERCULOSIS;

EID: 50549087699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002665     Document Type: Article

References (35)

1. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 3(12): e494. doi:10.1371/journal.pmed. 0030494.
2. Seidler A, Nienhaus A, Diel R (2005) Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 72(4): 431-446.
3. Diel R, Seidler A, Nienhaus A, Rusch-Gerdes S, Niemann S (2005) Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 6(1): 35-45.
4. De Vries G, Sebek MM, Lambregts-van Weezenbeek CS (2006) Health-care workers with tuberculosis infected during work. Eur Respir J 28(6): 1216-21.
5. Menzies D, Joshi R, Pai M (2007) Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11(6): 593-605.
6. World Health Organisation WHO report 2008 (2008) Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland.
7. Hill PC, Fox A, Jeffries D, Jackson-Sillah, Lugos MD, et al. (2005) Quantitative T cell assay refects infectious load of Mycobacterium tuberculosis in an endemic case control model. CID 40: 273-78.
8. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235): 1099-1104.
9. Pai M, Riley LW, Colford JM (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
10. Pai M (2005) Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J. Med. Microbiol 23(3): 151-158.
11. Nahid P, Pai M, Hopewell PC (2006) Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3: 103-110.
12. Mantoux MC (1912) La voie intradermique en tuberculinthérapie. Press Med 20: 146-48.
13. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146: 346-52.
14. Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, et al. (2007) Detection of mycobacteriumn tuberculosis infection in Unites States Navy recruits using the tuberculin skin test or whole-blood interferon-γ release assays. CID 45: 826-36.
15. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A (2008) Predictive Value of a Whole-blood IFN-gamma Assay for the Development of Active TB Disease. Am J Respir Crit Care Med 177: 1164-70.
16. Young DB, Perkins MD, Duncan K, Barry CL (2008) Confronting the scientific obstacles to global control of tuberculosis. The Journal of Clinical Investigation 118(4): 1255-1265.
17. Lalavani A (2007) Diagnosing tuberculosis infection in the 21st century - New tools to tackle an old enemy, CHEST 131(6): 1898-1906.
18. Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, et al. (2007) Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc lung Dis 11(9): 1021-1025.
19. Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc lung Dis 10(8): 942-944.
20. Diel R, Ernst M, Doscher G, Visuri-Karbe L, Nienhaus A, et al. (2006) Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 28(1): 16-23.
21. Nienhaus A, Schablon A, Siano B, le Bacle C, Diel R (2008) Evaluation of the Interferon-gamma Release Assay in Healthcare Workers. Int Arch Occup Environ Health 81: 295-300.
22. Robert Koch Institut (RKI) (2002) Vaccination preventable diseases in Germany until 2000 (Impfpräventable Krankheiten in Deutschland bis zum Jahr 2000). Epidem Bulletin 7: 49-57.
23. Infuso A, Falzon D (2006) European survey of BCG vaccination policies and surveillance in children, 2005. eurosurveillance 11(1-3): 6-11.
24. Hosmer D, Lemeshow S (2000) Applied Logistic Regression. New York, NY: John Wiley & Sons.
25. Franken WPJ, Timmermans JT, Prins C, Slootman EJ, Dreverman J, et al. (2007) Comparision of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in army personnel. Clinical and Vaccine Immunology. pp 477-480. doi:10.1128/CVI.00463-06.
26. Keskiner R, Ergönül Ö, Demiroglu Z, Eren S, Baykam N, et al. (2004) Risk of tuberculous infection among healthcare workers in a tertiary-care hospital in Ankara, Turkey. Infection Control and Hospital Epidemiology 25(12): 1067-1071.
27. Farhat M, Greenaway, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11): 1192-1204.
28. Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma asays. Int J Tuberc Lung Dis 10(8): 942-944.
29. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, et al. (2006) Screening for Tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infection control and hospital epidemiology 27(5): 442-448.
30. Simon and Gutland (1988) The tuberculin test in the clinic - dosage and evaluation. Prax Klin Pneumol (Germany) 42(6): 423-426.
31. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries J, et al. (2007) Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Medicine 4(6): 1061-70.
32. Diel R, Forßbohm M, Loytved G, Haas W, Hauer B, et al. (2007) Recommendations for background studies in tuberculosis. German Central Commitee against Tuberculosis Pneumologie 61: 440-455.
33. Barsegian V, Mathias KG, Wrighton-Smith P, Grose-Wilde H, Lindemann M (2008) Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect; doi:10.1016/j.jhin.2008.02.009.
34. World Health Organisation (2008) WHO report 2008. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland. pp 1-291.
35. RKI (2002) (Diseases without vaccination in Germany until 2000) Impfpräventable Krankheiten in Deutschland bis zum Jahr 2000. Epidemiologisches Bulletin 7: 49-57.